您的购物车当前为空
CMKLR1 antagonist 1 (compound S-26d) 为口服型趋化因子样受体 1 (CMKLR1) 拮抗剂,其在hCMKLR1感染的CHO细胞中表现出pIC50值达7.44。该化合物适用于银屑病和代谢性疾病的研究。
CMKLR1 antagonist 1 (compound S-26d) 为口服型趋化因子样受体 1 (CMKLR1) 拮抗剂,其在hCMKLR1感染的CHO细胞中表现出pIC50值达7.44。该化合物适用于银屑病和代谢性疾病的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
CMKLR1 antagonist 1 相关产品
| 产品描述 | CMKLR1 antagonist 1 (compound S-26d) is a potent, orally active antagonist of the chemokine-like receptor 1 (CMKLR1), exhibiting a pIC50 of 7.44 in hCMKLR1-transfected CHO cells. It is applicable in the research of psoriasis and metabolic diseases [1]. |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容